Xilio Therapeutics Inc (XLO) PT Lowered to $25 at Guggenheim
Tweet
Share
E-mailGet Alerts XLO Hot Sheet
Price: $8.70 -2.79%
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Guggenheim analyst Michael W. Schmidt lowered the price target on Xilio Therapeutics Inc (NASDAQ: XLO) to $25.00 (from $40.00) while maintaining a Buy rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Ultrapar Participacoes SA (UGPA3:BZ) (UGP) PT Raised to BRL39 at JPMorgan
- Callaway Golf (CALY) PT Raised to $20 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
